학술논문
Use of the BelloCell System to Determine the Optimal Dose of Ribavirin to Inhibit the Expression of an HCV Replicon in 2209-23 Cells
Document Type
Abstract
Source
In Antiviral Research May 2009 82(2):A30-A30
Subject
Language
ISSN
0166-3542